secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2026-10-01T13:00:50+00:00
Accession:  0001493152-26-045275
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Daré Bioscience to use Oct 1, 2026 investor presentation in meetings; exhibit content not filed
--------------------------------------------------------------------------------

- A corporate presentation dated October 1, 2026 is to be used in meetings with securities market participants and others, starting October 1, 2026.
- The presentation is to be posted in the 'Investors' section of ir.darebioscience.com under 'Presentations, Events & Webcasts' > 'Presentations'.
- The filing references Exhibit 99.1 but the presentation text was not included, so no financial, clinical, or pipeline figures can be reported.
- Item 7.01 Regulation FD disclosure; no revenue, guidance, trial data, partnership, or financing terms appear anywhere in the text provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315226045275/0001493152-26-045275-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315226045275/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-045275

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer